Lung cancer drug approval: Is it the best option for patients?

Lung cancer drug approval is a significant milestone for Alembic Pharma, enhancing treatment options.

Cancer Drug Price Cuts: Smart Move to Save Rs 3,502 Crore

Cancer drug price cuts are set to save Rs 3,502 crore annually, benefiting patients and healthcare.

Cancer Drug Prices: Clear Path to 70% Savings Ahead

Cancer drug prices could see a significant drop of up to 70% due to government action.